• roche logo

Principal publications.

To obtain copies of manuscripts regarding HPV and clinical research, choose from the links below:

The Budget Impact of Cervical Cancer Screening Using HPV Primary Screening
Wright TC Jr, Huan J, Baker E, Garfield S, Hertz, and Cox JT. Am J Managed Care 2016; 22(3):e95e105-197.

Primary cervical cancer screening with human papillomavirus: End of study results from the ATHENA study using HPV as the first-line screening test
Wright TC Jr, Stoler MH, Behrens CM, Sharma A, Zhang Wright TL. Gyn Onc 2015; 136:189-197.

Relevance of Random Biopsy at the Transformation Zone When Colposcopy Is Negative
Huh KH, Sideri M, Stoler MH, Zhang G, Feldman R, and Behrens CM. Obstetrics and Gynecology 2014; 124(4):670-678.

Interlaboratory variation in the performance of liquid-based cytology: Insights from the ATHENA trial
Wright TC Jr, Stoler MH, Behrens CM, Sharma A, Sharma K, and Apple R. Int J Cancer 2014; 134:1835-1843.

Evaluation of HPV-16 and HPV-18 Genotyping for the Triage of High-risk HPV Positive Cytology Negative Women
Wright TC Jr, Stoler MH, Sharma A, Zhang G, Behrens CM, Wright TL. Am J Clin Pathol 2011; 136:578-586.

High-Risk Human Papillomavirus Testing in Women With ASC-US Cytology. Results From the ATHENA HPV Study
Stoler MH, Wright TC Jr, Sharma A, Apple R, Gutekunst K, Wright TL. Am J Clin Pathol 2011; 135:468-475.

The Interplay of Age Stratification and HPV Testing on the Predictive Value of ASC-US Ctyology. Results from the ATHENA HPV Study
Stoler, MH, Wright TC Jr, Sharma A, Zhang G, Apple R, Wright TL, Behrens CM. Am J Clin Pathol 2012; 137:295-303.

Comparison of cervical cancer screening strategies incorporating different combinations of cytology, HPV testing, and genotyping for HPV 16/18: results from the ATHENA HPV study
Cox JT, Castle PE, Behrens CM, et al. Am J Obstet Gynecol 2012; 184:e1-e11.

Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study 
Castle PE, Stoler MH, Wright TC Jr., et al. Lancet Oncol 2011; 12:880-890.

The ATHENA human papillomavirus study: design, methods, and baseline results
Wright TC Jr, Stoler MH, Behrens CM, Apple R, Derion T, Wright TL. Am J Obstet Gynecol 2011; 1:e1-e11.


 

The landmark ATHENA study demonstrated that primary HPV screening is an effective strategy for determining the likelihood that women age 25+ will develop high-grade cervical disease.

Learn how the ATHENA HPV trial was designed

  • Acronyms: